A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy
- 1 August 2010
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 78 (3), 257-268
- https://doi.org/10.1038/ki.2010.154
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathyAmerican Journal of Physiology-Renal Physiology, 2009
- Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activationThe Journal of Experimental Medicine, 2009
- Enhanced Expression of Janus Kinase–Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic NephropathyDiabetes, 2009
- STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord InjuryJournal of Neuroscience, 2008
- Basal c-Jun N-terminal kinases promote mitotic progression through histone H3 phosphorylationCell Cycle, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Role of Wnt/β‐catenin signaling pathway in epithelial‐mesenchymal transition of human prostate cancer induced by hypoxia‐inducible factor‐1αInternational Journal of Urology, 2007
- Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityProceedings of the National Academy of Sciences of the United States of America, 2007
- Susceptibility of Signal Transducer and Activator of Transcription-1-Deficient Mice to Pulmonary FibrogenesisThe American Journal of Pathology, 2005
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996